Role of tumour markers in monitoring epithelial ovarian cancer

T Meyer, G J Rustin, T Meyer, G J Rustin

Abstract

Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various criteria, but it does not yet have a clear place in diagnosis or prognosis. Its value as part of a screening tool and during routine follow-up remain the subject of ongoing trials. Other markers remain experimental and do not have a well-defined contribution to make at present.

References

    1. Am J Obstet Gynecol. 1989 Nov;161(5):1213-6
    1. J Clin Oncol. 1996 May;14(5):1545-51
    1. Cancer. 1995 Nov 15;76(10 Suppl):2004-10
    1. Gynecol Oncol. 1992 Oct;47(1):87-92
    1. J Clin Oncol. 1999 Feb;17(2):501-8
    1. Br J Obstet Gynaecol. 1990 Oct;97(10):922-9
    1. Gynecol Oncol. 1996 Feb;60(2):197-202
    1. BMJ. 1993 Apr 17;306(6884):1030-4
    1. Cancer. 1996 Jul 1;78(1):118-27
    1. Cancer Res. 1998 May 1;58(9):1843-9
    1. Int J Gynecol Cancer. 1993 Sep;3(5):285-292
    1. Gynecol Oncol. 1993 Dec;51(3):297-8
    1. Cancer Treat Rev. 1995 May;21(3):215-45
    1. N Engl J Med. 1983 Oct 13;309(15):883-7
    1. Obstet Gynecol. 1995 Aug;86(2):259-64
    1. Am J Clin Oncol. 1982 Dec;5(6):649-55
    1. Ann Oncol. 1993;4 Suppl 4:71-7
    1. Lancet. 1999 Apr 10;353(9160):1207-10
    1. Lancet. 1988 Feb 6;1(8580):268-71
    1. Gynecol Oncol. 1988 Jul;30(3):307-12
    1. Obstet Gynecol. 1987 Feb;69(2):223-7
    1. Gynecol Oncol. 1995 Oct;59(1):111-6
    1. J Clin Invest. 1981 Nov;68(5):1331-7
    1. Ann Oncol. 1996 Apr;7(4):361-4
    1. Obstet Gynecol. 1986 Apr;67(4):473-7
    1. Cancer. 1981 Jan 1;47(1):207-14
    1. J Natl Cancer Inst. 1993 Nov 3;85(21):1748-51
    1. Ann Oncol. 1997 Oct;8(10):963-8
    1. Am J Clin Oncol. 1989 Apr;12(2):106-9
    1. Gynecol Oncol. 1994 Jun;53(3):339-43
    1. Obstet Gynecol. 1992 Jul;80(1):14-8
    1. J Clin Oncol. 1993 Aug;11(8):1506-10
    1. Eur J Cancer. 1992;28(1):79-82
    1. Ann Oncol. 1990 Jul;1(4):301-2

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir